+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
From
From
Anti Dermatomycosis Skin Drugs Companies in China - Product Thumbnail Image

Anti Dermatomycosis Skin Drugs Companies in China

  • Report
  • April 2025
  • 71 Pages
  • China
From
From
Dermatologicals in India - Product Thumbnail Image

Dermatologicals in India

  • Report
  • January 2025
  • 24 Pages
  • India
From
Dermatologicals in Germany - Product Thumbnail Image

Dermatologicals in Germany

  • Report
  • November 2024
  • 25 Pages
  • Germany
From
Dermatologicals in Taiwan - Product Thumbnail Image

Dermatologicals in Taiwan

  • Report
  • October 2024
  • 25 Pages
  • Taiwan
From
Dermatologicals in Saudi Arabia - Product Thumbnail Image

Dermatologicals in Saudi Arabia

  • Report
  • October 2024
  • 24 Pages
  • Saudi Arabia
From
Dermatologicals in Australia - Product Thumbnail Image

Dermatologicals in Australia

  • Report
  • September 2024
  • 26 Pages
  • Australia
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more